Comparison of Ranibizumab and Aflibercept in Patients with Neovascular Age-Related Macular Degeneration treated following a 'Treat and Extend' protocol: efficacy variables from the pre-specified 12-month interim analysis of the RIVAL study

被引：0
|
作者：
Gillies, Mark C. [1 ]
Hunyor, Alex [1 ]
Arnold, Jennifer [2 ]
Pecheur, Francois [3 ]
Underhill, Kathryn [3 ]
Guymer, Robyn H. [4 ]
McAllister, Ian [5 ]
机构：
[1] Univ Sydney, Ophthalmol, Sydney, NSW, Australia
[2] Marsden Eye Specialists, Parramatta, NSW, Australia
[3] Novartis Pharmaceut, Sydney, NSW, Australia
[4] CERA, Sydney, NSW, Australia
[5] Lions Eye Inst, Perth, WA, Australia
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
840
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Assessment of Mental Burden of Patients with Neovascular Age-Related Macular Degeneration Treated by Treat-and-Extend Regimen with Intravitreal Ranibizumab
    Kato, Aki
    Yasukawa, Tsutomu
    Sugita, Iichiro
    Yoshida, Munenori
    Nozaki, Miho
    Hirano, Yoshio
    Kondo, Junko
    Abe, Tomohiro
    Sugita, Kimiko
    Okita, Takahide
    Morita, Hiroshi
    Sugitani, Kazuhiko
    Usui, Hideaki
    Niwa, Naomi
    Kato, Fusae
    Ogura, Yuichiro
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [22] A Comparative Study of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration: 12-Month Outcomes of Polish Therapeutic Program in Non-Tertiary Institution
    Skrzypczak, Tomasz
    Jany, Aleksandra
    Bugajska-Abramek, Ewa
    Kowal-Lange, Agnieszka
    Boguslawska, Joanna
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
  • [23] Transitioning Neovascular Age Related Macular Degeneration Patients to Aflibercept Following an Initial Treat And Extend Dosing Regimen: 18 Month Results
    Homer, Natalie
    Grewal, Dilraj Singh
    Lyon, Alice T.
    Mirza, Rukhsana
    Gill, Manjot
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [24] Visual and anatomical outcomes following intravitreal aflibercept in eyes with recalcitrant neovascular age-related macular degeneration: 12-month results
    D S Grewal
    M K Gill
    D Sarezky
    A T Lyon
    R G Mirza
    Eye, 2014, 28 : 895 - 899
  • [25] Visual and anatomical outcomes following intravitreal aflibercept in eyes with recalcitrant neovascular age-related macular degeneration: 12-month results
    Grewal, D. S.
    Gill, M. K.
    Sarezky, D.
    Lyon, A. T.
    Mirza, R. G.
    EYE, 2014, 28 (07) : 895 - 899
  • [26] Long-Term Efficacy of a Treat-and-Extend Regimen with Ranibizumab in Patients with Neovascular Age-Related Macular Disease: An Open-Label 12-Month Extension to the CANTREAT Study
    Kertes, Peter J.
    Sheidow, Tom
    Williams, Geoff
    Greve, Mark
    Galic, Ivan J.
    Baker, Jason
    OPHTHALMOLOGICA, 2022, 245 (03) : 230 - 238
  • [27] Comparison of Progression Rate of Retinal Pigment Epithelium Loss in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab and Aflibercept
    Wons, Juliana
    Wirth, Magdalena A.
    Graf, Nicole
    Becker, Matthias D.
    Michels, Stephan
    JOURNAL OF OPHTHALMOLOGY, 2017, 2017
  • [28] A 12-month, prospective, observational study of ranibizumab in treatment-naive Taiwanese patients with neovascular age-related macular degeneration: the RACER study
    Wu, Wen-Chuan
    Chen, Jiann-Torng
    Tsai, Ching-Yao
    Wu, Chien-Liang
    Cheng, Cheng-Kuo
    Shen, Yun-Dun
    Tsai, Arslan
    Wu, Pei-Chang
    BMC OPHTHALMOLOGY, 2020, 20 (01)
  • [29] Efficacy of Intravitreal Aflibercept Treat-and-Extend Regimen Over 2 Years for Neovascular Age-Related Macular Degeneration: ARIES Study
    Souied, Eric H.
    Holz, Frank G.
    Hykin, Philip G.
    Midena, Edoardo
    Wolf, Sebastian
    Allmeier, Helmut
    Mitchell, Paul
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [30] Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration Results with Ranibizumab from the TREND Study
    Silva, Rufino
    Berta, Andras
    Larsen, Michael
    Macfadden, Wayne
    Feller, Chrystel
    Mones, Jordi
    OPHTHALMOLOGY, 2018, 125 (01) : 57 - 65
12345